Co-administration of single-dose furosemide with steady-state oral semaglutide resulted in a 28% increase in total furosemide exposure (AUC 0 ) and a 34% decrease in C max compared with patients not receiving oral semaglutide
But the indication for the drug isn't BMI of 30 and has tried a bunch of other stuff
Mikki may recommend combining it with hormone replacement therapy for comprehensive hormonal optimization, NAD+ therapy for cellular energy and longevity, MOTS-C for metabolic support, aesthetic treatments to complement internal wellness with external rejuvenation, and medical weight management if body composition is a primary goal
Users of weight-loss therapies based on GLP-1 agonists have been warned to be aware of a rare complication, pancreatitis, that can be severe
Pharmacokinetic differences that matter for switching Half-life determines how long a compound stays active in your system
Im on my second week and lost 7lbs